Olopatadine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 17 USDMF, 9 JDMF, 6 EU WC, 14 KDMF, 14 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 35 FDA Orange Book, 13 Europe, 13 Canada, 2 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE, SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 2 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 19 Controlled & Modified Release, 14 Direct Compression, 12 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Parenteral, 11 Solubilizers, 10 Granulation, 9 Disintegrants & Superdisintegrants, 7 Film Formers & Plasticizers, 7 Co-Processed Excipients, 6 Thickeners and Stabilizers, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Topical, 2 Coloring Agents, 1 Lubricants & Glidants, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents

DIGITAL CONTENT

48 News #PharmaBuzz

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 17 Annual Reports

MARKET PLACE

18 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21861 / DOSAGE - SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OLOPATADINE HYDROCHLORIDE(UNII: 2XG66W44KF) (OLOPATADINE - UNII:D27V6190PM)	OLOPATADINE	665ug

Inactive Ingredients

Ingredient Name	Alcon Laboratories, Inc.	Clinical Solutions Wholesale	Novartis Pharmaceuticals Corporation	Perrigo New York Inc
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
EDETATE DISODIUM(7FLD91C86K)
HYDROCHLORIC ACID(QTT17582CB)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
SODIUM PHOSPHATE, DIBASIC(GR686LBA74)
WATER(059QF0KO0R)

Drug Product Composition: Olopatadine Hydrochloride